AGARWALEYE Reports Q2 Revenue of ₹560 Crore Versus ₹427 Crore YoY

Market snapshot: Dr. Agarwal's Health Care Limited (AGARWALEYE) reported its Q2 financial results, highlighted by a revenue increase to ₹560 crore compared to ₹427 crore in the same period last year. The expansion was driven by increased surgical procedure volume and ongoing network expansion.

Data Snapshot

• Q2 Revenue expanded to ₹560 crore from ₹427 crore in the prior-year quarter, reflecting a 31.15% YoY growth.
• Surgical procedure volume reached 95,841 in Q2, representing a 22.2% YoY increase.
• Total network scale reached 324 facilities as of September 30, 2026, following 21 new center additions during the quarter.
• H1 FY27 Revenue from operations reached ₹1,269 crore, marking a 28.7% YoY increase.

What's Changed

• Quarterly revenue grew by 31.15% YoY from ₹427 crore to ₹560 crore.
• Quarterly surgical procedure volume rose 22.2% YoY to 95,841 surgeries.
• Added 21 new eye care centers in Q2, taking total network footprint to 324 facilities.

Key Takeaways

• Top-line expansion was led by a 22.2% YoY increase in surgical procedures across the network.
• Network capacity expanded with 21 new centers added in Q2 FY27 comprising 1 tertiary, 17 secondary, and 3 primary facilities.
• H1 FY27 revenue grew 28.7% YoY to ₹1,269 crore, demonstrating consistent revenue execution.

SAHI Perspective

Dr. Agarwal's Health Care continues to demonstrate operative execution through combined procedure volume growth and network expansion. The 22.2% YoY growth in surgical procedures underpins top-line momentum, while adding 21 new locations in a single quarter expands patient reach across regional sub-markets.

Market Implications

The revenue growth trajectory reflects persistent demand for organized specialized eye care services in India. Strategic network scaling via secondary and primary centers creates operational leverage and enhances patient throughput.

Trading Signals

Market Bias: Bullish

Revenue expansion of 31.15% YoY to ₹560 crore combined with 22.2% YoY growth in surgical procedures reflects strong operational momentum.

Overweight: Healthcare Services, Eye Care Chains

Trigger Factors:

• Sustained quarterly surgical volume growth above 20% YoY
• Execution pace and bed monetization across newly added centers

Time Horizon: Near-term (0-3 months)

Industry Context

Organized single-specialty hospital chains, particularly in ophthalmology, benefit from structural demand tailwinds including rising prevalence of ocular disorders, aging demographics, and broader adoption of specialized cataract and refractive procedures.

Key Risks to Watch

• Gestational delays and initial operating drag from newly opened centers
• Competition from regional single-specialty eye care providers
• Availability and retention of skilled ophthalmic surgeon talent

Recent Developments

In Q2 FY27, Dr. Agarwal's Health Care added 21 new centers to its network, comprising 1 tertiary center, 17 secondary centers, and 3 primary clinics, expanding total network size to 324 facilities.

Closing Insight

With robust surgery volume growth driving top-line expansion, Dr. Agarwal's Health Care demonstrates the scalability of its hub-and-spoke eye care model.

High Performance Trading with SAHI.